Search

247 results for “Report”

• EditorialOpen Access

  Source of Support: Nil, Confl ict of Interest: None declared.

  Gitanjali B.

  Vol. 2 · Issue 2 · pp. 71–73

  https://doi.org/10.4103/0976-500X.81894
  Full text ↗PDF

• Research LettersOpen Access

  Effect of Erythrina variegata on experimental atherosclerosis in guinea pigs

  Mangathayaru Kalachaveedu, Sarah Kuruvilla, K. Balakrishna

  Vol. 2 · Issue 4 · pp. 285–287

  https://doi.org/10.4103/0976-500X.85949
  Full text ↗PDF

• Open Access

  Ceftaroline fosamil: A novel anti-Methicillin-resistant Staphylococcus aureus cephalosporin

  C. Girish, S. Balakrishnan

  Vol. 2 · Issue 3 · pp. 209–211

  https://doi.org/10.4103/0976-500X.83298
  Full text ↗PDF

• EditorialOpen Access

  Essential medicines for children: Should we focus on a priority list of medicines for the present?

  Gitanjali B

  Vol. 2 · Issue 1 · pp. 1–2

  https://doi.org/10.4103/0976-500X.77073
  Full text ↗PDF

• Educational ForumOpen Access

  Saxagliptin: A dipeptidyl peptidase-4 inhibitor in the treatment of type 2 diabetes mellitus

  Darshan J. Dave

  Vol. 2 · Issue 4 · pp. 230–235

  https://doi.org/10.4103/0976-500X.85934
  Full text ↗PDF

• Review ArticleOpen Access

  Adipocytokines: The pied pipers

  Hardik Gandhi, Aman Upaganlawar, Balaraman R

  Vol. 1 · Issue 1 · pp. 9–10

  https://doi.org/10.4103/0976-500X.64530
  Full text ↗PDF

• EditorialOpen Access

  The national essential medicines list of India: Time to revise and purge the mistakes

  Gitanjali B

  Vol. 1 · Issue 2 · pp. 73–74

  https://doi.org/10.4103/0976-500X.72346
  Full text ↗PDF